Publications
Original Article
The Immune Landscape of Cancer
2018
Authors:
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I
Journal:
Immunity
Volume:
48(4)
Page:
812-830
Pubmed:
Original Article
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
T Cell Function & Therapy
2017
Authors:
Pathangey LB, McCurry DB, Gendler SJ, Dominguez AL, Gorman JE, Pathangey G, Mihalik LA, Dang Y, Disis ML, Cohen PA.
Journal:
Oncotarget
Volume:
8(7)
Page:
10785-10808
Pubmed:
Original Article
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial
Tumor Microenvironment
2017
Authors:
Salazar, LG, Lu, H, Reichow, JL, Childs, JS, Coveler, AL, Higgins, DM, Waisman, J, Allison, KH, Dang, Y, and Disis, ML
Journal:
JAMA Oncology
Volume:
3(7)
Page:
969-973
Pubmed:
Original Article
Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo
Cancer Vaccines
2017
Authors:
Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.
Journal:
Clinical Cancer Research
Volume:
23(13)
Page:
3396-3404
Pubmed:
Original Article
Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer
Clinical Trials
2017
Authors:
John B Liao, Ron E Swensen , Kelsie J Ovenell , Katie M Hitchcock-Bernhardt, Jessica L Reichow, Minjun C Apodaca, Leonard D'Amico, Jennifer S Childs, Doreen M Higgins, Barbara J Buening, Barbara A Goff, Mary L Disis
Journal:
Gynecologic Oncology
Volume:
144(3)
Page:
480-485
Pubmed:
Original Article
Gene expression markers of Tumor Infiltrating Leukocytes
Tumor Microenvironment
2017
Authors:
Danaher P, Warren S, Dennis L, D'Amico L, White A, Disis ML, Geller MA, Odunsi K, Beechem J, Fling SP.
Journal:
Journal of Immunotherapy Cancer
Volume:
5
Page:
18
Pubmed:
Original Article
The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent
T Cell Function & Therapy
2016
Authors:
Vy Phan-Lai, Yushe Dang, Ekram Gad, Jennifer Childs, and Mary L. Disis
Journal:
Clinical Cancer Research
Volume:
22(9)
Page:
2207-16
Pubmed:
Original Article
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity
Tumor Microenvironment
2016
Authors:
Dietsch GN, Lu H, Yang Y, Morishima C, Chow LQ, Disis ML, Hershberg RM.
Journal:
PLoS One
Volume:
11(2)
Page:
e0148764
Pubmed:
Original Article
Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer
Cancer Vaccines
2016
Authors:
Ebben JD, Lubet RA, Gad E, Disis ML, You M.
Journal:
Molecular Carcinogensis
Volume:
55(11)
Page:
1517-1525
Pubmed:
Original Article
Leveraging premalignant biology for immune-based cancer prevention
General Immune Research
2016
Authors:
Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM.
Journal:
Proceeding of the National Academy of sciences of the United States of America
Volume:
113(39)
Page:
10750-8
Pubmed: